Regeneration of neuronal cells following cerebral injury

Frontiers of Neurology and Neuroscience

Volumn 32, Issue , 2013, Pages 54-61

  Dailey, Travis ^a   Tajiri, Naoki ^a   Kaneko, Yuji ^a   Borlongan, Cesar V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW; BRAIN INJURY; BRAIN ISCHEMIA; CELL REGENERATION; HUMAN; NERVE REGENERATION; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; STEM CELL; SUBVENTRICULAR ZONE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL STRUCTURE; CEREBROVASCULAR DISEASE; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; FUNCTIONAL DISEASE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; MESENCHYMAL STEM CELL; NERVE CELL; NERVE CELL PLASTICITY; PATHOGENESIS; PROTEIN EXPRESSION; STEM CELL RESEARCH; THERAPY EFFECT;

ANIMALS; BRAIN ISCHEMIA; HUMANS; NERVE REGENERATION; NEURONS; REGENERATION; STEM CELLS;

BRAIN DERIVED NEUROTROPHIC FACTOR; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; NERVE GROWTH FACTOR; NITRIC OXIDE DONOR; SCATTER FACTOR; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; TELOMERASE; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

EID: 84880955235     PISSN: 16604431     EISSN: 16622804     Source Type: Book Series    
DOI: 10.1159/000346407     Document Type: Article

References (30)

1. Hess DC, Borlongan CV: Stem cells and neurological diseases. Cell Prolif 2008; 41(suppl 1):94-114.
2. Munoz-Elias G, Woodbury D, Black IB: Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions. Stem Cells 2003; 21: 437-448.
3. Borlongan CV, et al: Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med 2008; 3: 249-250.
4. Lapidot T, Kollet O: The brain-bone-blood triad: traffic lights for stem-cell homing and mobilization. Hematology Am Soc Hematol Educ Program 2010, pp 1-6.
5. Lapidot T, Dar A, Kollet O: How do stem cells find their way home? Blood 2005; 106: 1901-1910.
6. Dar A, Kollet O, Lapidot T: Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 2006; 34: 967-975.
7. Stumm RK, et al: A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoformselective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 2002; 22: 5865-5878.
8. Kalinkovich A, et al: Blood-forming stem cells are nervous: direct and indirect regulation of immature human CD34+ cells by the nervous system. Brain Behav Immun 2009; 23: 1059-1065.
9. Dunac A, et al: Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization. J Neurol 2007; 254: 327-332.
10. Bajada S, et al: Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2008; 2: 169-183.
11. Shen LH, et al: Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 2007; 27: 6-13.
12. Chen J, et al: Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 2003; 92: 692-699.
13. Zhang ZG, et al: VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000; 106: 829-838.
14. Zimmermann S, et al: Lack of telomerase activity in human mesenchymal stem cells. Leukemia 2003; 17: 1146-1149.
15. Kurozumi K, et al: Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 2005; 11: 96-104.
16. Chen J, Li Y, Chopp M: Intracerebral transplantation of bone marrow with BDNF after MCAo in rat. Neuropharmacology 2000; 39: 711-716.
17. Chen J, et al: Caspase inhibition by Z-VAD increases the survival of grafted bone marrow cells and improves functional outcome after MCAo in rats. J Neurol Sci 2002; 199: 17-24.
18. Chen J, et al: Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res 2004; 1005: 21-28.
19. Ceradini DJ, Gurtner GC: Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 2005; 15: 57-63.
20. Lapergue B, Mohammad A, Shuaib A: Endothelial progenitor cells and cerebrovascular diseases. Prog Neurobiol 2007; 83: 349-362.
21. Griese DP, et al: Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cellbased vascular therapy. Circulation 2003; 108: 2710-2715.
22. Masuda H, Asahara T: Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 2003; 58: 390-398.
23. Kucia M, et al: Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia 2007; 21: 297-303.
24. Zuba-Surma EK, et al: Optimization of isolation and further characterization of umbilical-cord-bloodderived very small embryonic/epiblast- like stem cells (VSELs). Eur J Haematol 2010; 84: 34-46.
25. Ratajczak J, et al: Stem cells for neural regeneration-A potential application of very small embryonic-like stem cells. J Physiol Pharmacol 2011; 62: 3-12.
26. Ratajczak J, et al: Membrane-derived microvesicles: important and underappreciated mediators of cell-tocell communication. Leukemia 2006; 20: 1487-1495.
27. Lu P, Blesch A, Tuszynski MH: Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? J Neurosci Res 2004; 77: 174-191.
28. Kaneko Y, Tajiri N, Shinozuka K, Glover LE, Weinbren NL, Cortes L, Borlongan CV: Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells. Curr Pharm Des 2012; 18: 3731-3734.
29. Borlongan CV, Glover LE, Tajiri N, Kaneko Y, Freeman TB: The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Prog Neurobiol 2011; 95: 213-228.
30. Borlongan CV: Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all! Leukemia 2011; 25: 1674-1686.